ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 134 filers reported holding ANAPTYSBIO INC in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $187,000 | -97.8% | 11,500 | -90.0% | 0.04% | -98.4% |
| Q1 2019 | $8,401,000 | -5.9% | 115,000 | -17.9% | 2.20% | -32.3% |
| Q4 2018 | $8,931,000 | +49.2% | 140,000 | +133.3% | 3.24% | +154.8% |
| Q3 2018 | $5,986,000 | +436.9% | 60,000 | +282.2% | 1.27% | +287.8% |
| Q2 2018 | $1,115,000 | +19.0% | 15,700 | +74.4% | 0.33% | +72.6% |
| Q1 2018 | $937,000 | – | 9,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $371,500,000 | 60.25% |
| Cormorant Asset Management, LP | 1,251,485 | $126,050,000 | 13.20% |
| BVF INC/IL | 594,397 | $59,868,000 | 7.22% |
| VHCP Management II, LLC | 282,550 | $28,458,000 | 6.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 812,484 | $81,833,000 | 3.22% |
| Iguana Healthcare Management, LLC | 40,000 | $4,029,000 | 2.62% |
| Perceptive Advisors | 756,387 | $76,183,000 | 2.52% |
| Cormorant Asset Management, LP | 135,000 | $13,597,000 | 1.42% |
| EAM Global Investors LLC | 21,734 | $2,189,000 | 1.12% |
| PFM Health Sciences, LP | 425,896 | $42,896,000 | 1.02% |